NERISALIC OILY CREAM DIN 02028719
Status: Cancelled Post Market
Holder: GLAXOSMITHKLINE INC
Health Canada record
| Active ingredient(s) | DIFLUCORTOLONE VALERATE 0.1 %; SALICYLIC ACID 3.0 % |
|---|
| Dosage form | Cream |
|---|
| Route | Topical |
|---|
| Schedule | PRESCRIPTION |
|---|
| Class | Human |
|---|
| ATC | D07XC04 DIFLUCORTOLONE |
|---|
| Original market date | 31-Dec-1995 |
|---|
| Current status date | 21-Feb-2012 |
|---|
| Source | Health Canada DPD |
|---|
Establishment licence of the holder
GlaxoSmithKline Inc. — licence 100630, currently licensed, last inspection rating C (2025-09-15).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing DIFLUCORTOLONE VALERATE
| DIN | Product | Company | Form | Strength | Status |
|---|
| 00587826 | NERISONE CREAM | GLAXOSMITHKLINE INC | Cream | DIFLUCORTOLONE VALERATE 0.1 % | Cancelled Post Market |
| 00587818 | NERISONE OILY CREAM | GLAXOSMITHKLINE INC | Cream | DIFLUCORTOLONE VALERATE 0.1 % | Cancelled Post Market |
| 00587834 | NERISONE OINTMENT | GLAXOSMITHKLINE INC | Ointment | DIFLUCORTOLONE VALERATE 0.1 % | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|
| 11397 | 2010-05-20 | New Drug Submission (NDS) | Manufacturer name change |
Request a quote for NERISALIC OILY CREAM
How to read a Canadian DIN record